Stocks To Buy

The overall stock market dropped last week amidst a deluge of corporate earnings. Among a sold-off name is an industrial giant that has been making some modern pivots. While sales dropped last year, the company managed to grow earnings year-over-year. Even better? The firm gave a buoyant outlook that indicated a move towards higher growth in the year ahead. The firm? Honewell (HON). It’s a name best known for air conditioning equipment and other “old-school” industrial products. The company is making big ...
Read More

Traders looking for other short-squeeze alternatives to GameStop (GME) are turning their eyes toward silver. Why? The commodity is seeing lower annual mining production, while demand for it increases thanks to a variety of uses in electronic components. Meanwhile, big banks are able to play the silver market by selling contracts, earning a small amount on each trade, but making millions of trades. The disconnect between this paper market and the physical metals market has grown extreme. This idea isn’t new. It ...
Read More

For the first time in five years, Amazon (AMZN) isn’t the reigning global brand. Rather, the title is going back to a name that had it before. The company? Apple (AAPL). It’s the ultimate consumer tech play. While the company can be derided for coming up with small improvements in its tech every year, a rabid fan base and a growing services division continues to reward shareholders. The company’s increased investment in streaming, electric cars, and other trends have already allowed it ...
Read More

The pandemic and related lockdowns have left some better off. For others, job losses have led to a challenge. The end result? A K-shaped recovery, as some trend higher and some lower. With that theme in mind, there are plenty of investment opportunities. Many consumers, particularly on the lower-end, are likely to continue their shift towards lower-priced consumer goods. That bodes particularly well for outlets such as dollar stores. One company getting an upgrade from Loop Capital on that thesis is Dollar ...
Read More

With a number of areas removing Covid-related restrictions thanks to the availability of multiple vaccines, capital is likely to start moving out of these names and into other potential fast-movers. One such area might be adjacent, into the biotech space. Companies that focus on other health issues are likely to see increased interest now that the focus is shifting away from Covid. It’s an opportunity-rich environment. One such name is Regeneron Pharmaceuticals (REGN). Shares declined in the second half of 2020, but ...
Read More

The energy industry has changed rapidly over the past decade. The growth of alternatives, and their improving costs, have made them viable compared to the use of fossil fuels. Even oil is under distress thanks to the rise of electric and hybrid vehicles impacting demand. It’s clear that fossil fuel companies need to embrace this change, and many already have. But even those with a small stake at a giant company can push through smart changes that improve sustainability and profitability. That ...
Read More

Restaurant stocks have fared relatively well the past few months on news of a Covid vaccine rollout. While that’s still an ongoing concern, the big move higher for restaurant stocks suggests a pause right now. That’s the case with MKM Partners, who has reiterated a neutral rating for coffee chain Starbucks (SBUX). Given that “sell” is a four-letter word on Wall Street, even a neutral rating suggests poor performance ahead. The rationale for the move is that same-store sales are likely to ...
Read More

Healthcare companies have seen renewed interest in the past year due to the Covid pandemic. But as capital flooded into the space, some companies fared better than others. Those best prepared for developing a vaccine for Covid have had excellent returns, while companies working on other pressing healthcare issues have struggled. A number of firms working on prospective drugs and treatments look set to have an excellent year as Covid recedes. That could offer traders market-beating opportunities. Case in point? Gilead Sciences ...
Read More